Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Coronary Artery Disease: HELP
Articles from Milan
Based on 686 articles published since 2009
||||

These are the 686 published articles about Coronary Artery Disease that originated from Milan during 2009-2019.
 
+ Citations + Abstracts
Pages: 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · 11 · 12 · 13 · 14 · 15 · 16 · 17 · 18 · 19 · 20
1 Guideline A Multidisciplinary Approach on the Perioperative Antithrombotic Management of Patients With Coronary Stents Undergoing Surgery: Surgery After Stenting 2. 2018

Rossini, Roberta / Tarantini, Giuseppe / Musumeci, Giuseppe / Masiero, Giulia / Barbato, Emanuele / Calabrò, Paolo / Capodanno, Davide / Leonardi, Sergio / Lettino, Maddalena / Limbruno, Ugo / Menozzi, Alberto / Marchese, U O Alfredo / Saia, Francesco / Valgimigli, Marco / Ageno, Walter / Falanga, Anna / Corcione, Antonio / Locatelli, Alessandro / Montorsi, Marco / Piazza, Diego / Stella, Andrea / Bozzani, Antonio / Parolari, Alessandro / Carone, Roberto / Angiolillo, Dominick J / Anonymous911159 / Anonymous921159 / Anonymous931159 / Anonymous941159 / Anonymous951159 / Anonymous961159 / Anonymous971159 / Anonymous981159 / Anonymous991159 / Anonymous1001159 / Anonymous1011159 / Anonymous1021159 / Anonymous1031159 / Anonymous1041159 / Anonymous1051159 / Anonymous1061159 / Anonymous1071159 / Anonymous1081159 / Anonymous1091159 / Anonymous1101159 / Anonymous1111159 / Anonymous1121159 / Anonymous1131159. ·Dipartimento Emergenze e Aree Critiche, Ospedale Santa Croce e Carle, Cuneo, Italy. Electronic address: roberta.rossini2@gmail.com. · Department of Cardiac, Thoracic and Vascular Sciences, University of Padua Medical School, Padua, Italy. · Dipartimento Emergenze e Aree Critiche, Ospedale Santa Croce e Carle, Cuneo, Italy. · Division of Cardiology, Department of Advanced Biomedical Sciences, Federico II University, Naples, Italy. · Division of Cardiology, Department of Cardio-Thoracic Sciences, Università degli Studi della Campania "Luigi Vanvitelli," Naples, Italy. · Division of Cardiology, Cardio-Thoracic-Vascular Department, Azienda Ospedaliero Universitaria "Policlinico-Vittorio Emanuele, Catania, Italy; Department of General Surgery and Medical-Surgical Specialties, University of Catania, Catania, Italy. · Coronary Care Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. · Cardiovascular Department, Humanitas Research Hospital, Rozzano, Italy. · U.O.C. Cardiologia, Azienda USL Toscana Sudest, Grosseto, Italy. · Unità Operativa di Cardiologia, Azienda Ospedaliero-Universitaria di Parma, Italy. · U.O.C. Cardiologia Interventistica, Anthea Hospital, GVM Care & Research, Bari, Italy. · Cardiology Unit, Cardio-Thoraco-Vascular Department, University Hospital of Bologna, Policlinico S. Orsola-Malpighi, Bologna, Italy. · Swiss Cardiovascular Centre Bern, Bern University Hospital, Bern, Switzerland. · Degenza Breve Internistica e Centro Trombosi ed Emostasi, Dipartimento di Medicina e Chirurgia, Università dell'Insubria, Varese, Italy. · Department of Immunohematology and Transfusion Medicine, Thrombosis and Hemostasis Center, ASST Papa Giovanni XXIII, Bergamo, Italy. · Department of Anaesthesia and Critical Care, AORN Dei Colli, Naples, Italy. · Dipartimento di Chirurgia Generale, Humanitas Research Hospital and University, Milano, Italy. · Policlinico Vittorio Emanuele di Catania, Catania, Italy. · Chirurgia Vascolare, Università di Bologna, Ospedale Sant'Orsola-Malpighi, Bologna, Italy. · UOC Chirurgia Vascolare, Dipartimento di Scienze Chirurgiche, Fondazione I.R.C.C.S. Policlinico San Matteo, Pavia, Italy. · Dipartimento di Scienze Biomediche per la Salute, Policlinico San Donato IRCCS, University of Milano, Milan, Italy. · Azienda Ospedaliera Universitaria Città della salute e della scienza, Torino, Italy. · Division of Cardiology, University of Florida, College of Medicine-Jacksonville, Jacksonville, Florida. ·JACC Cardiovasc Interv · Pubmed #29519377.

ABSTRACT: Perioperative management of antithrombotic therapy in patients treated with coronary stents undergoing surgery remains poorly defined. Importantly, surgery represents a common reason for premature treatment discontinuation, which is associated with an increased risk in mortality and major adverse cardiac events. However, maintaining antithrombotic therapy to minimize the incidence of perioperative ischemic complications may increase the risk of bleeding complications. Although guidelines provide some recommendations with respect to the perioperative management of antithrombotic therapy, these have been largely developed according to the thrombotic risk of the patient and a definition of the hemorrhagic risk specific to each surgical procedure, key to defining the trade-off between ischemia and bleeding, is not provided. These observations underscore the need for a multidisciplinary collaboration among cardiologists, anesthesiologists, hematologists and surgeons to reach this goal. The present document is an update on practical recommendations for standardizing management of antithrombotic therapy management in patients treated with coronary stents (Surgery After Stenting 2) in various types of surgery according to the predicted individual risk of thrombotic complications against the anticipated risk of surgical bleeding complications. Cardiologists defined the thrombotic risk using a "combined ischemic risk" approach, while surgeons classified surgeries according to their inherent hemorrhagic risk. Finally, a multidisciplinary agreement on the most appropriate antithrombotic treatment regimen in the perioperative phase was reached for each surgical procedure.

2 Guideline [SICI-GISE Position paper: Use of Absorb BVS in clinical practice]. 2016

Tarantini, Giuseppe / Saia, Francesco / Capranzano, Piera / Cortese, Bernardo / Mojoli, Marco / Boccuzzi, Giacomo / Cuculo, Andrea / Geraci, Salvatore / Mattesini, Alessio / Oreglia, Jacopo / Summaria, Francesco / Testa, Luca / Berti, Sergio / Esposito, Giovanni / La Manna, Alessio / Limbruno, Ugo / Marchese, Alfredo / Mauro, Ciro / Tarantino, Fabio / Salvi, Alessandro / Santoro, Gennaro / Varbella, Ferdinando / Violini, Roberto / Musumeci, Giuseppe. ·Dipartimento di Scienze Cardiologiche, Toraciche e Vascolari, Policlinico Universitario, Padova. · Dipartimento Cardio-Toraco-Vascolare, Azienda Ospedaliero-Universitaria di Bologna, Policlinico S. Orsola-Malpighi, Bologna. · Dipartimento Cardiovascolare, Ospedale Ferrarotto, Università degli Studi, Catania. · Cardiologia Interventistica, A.O. Fatebenefratelli, Milano. · Cardiologia Interventistica, Azienda Sanitaria Locale Torino 2, Torino. · Dipartimento di Cardiologia, A.O. Ospedali Riuniti, Foggia. · Cardiologia Interventistica, Ospedale S. Giovanni di Dio, Agrigento. · Cardiologia Interventistica, Ospedale Moriggia Pelascini, Gravedona (CO). · Emodinamica, ASST Grande Ospedale Metropolitano Niguarda, Milano. · Dipartimento di Cardiologia, Policlinico Casilino, Roma. · Dipartimento di Cardiologia, IRCCS Policlinico S. Donato, S. Donato Milanese (MI). · U.O. Cardiologia Diagnostica ed Interventistica, Fondazione Toscana "Gabriele Monasterio", Ospedale del Cuore, Massa. · Dipartimento di Scienze Biomediche Avanzate, Università degli Studi "Federico II", Napoli. · U.O.C. Cardiologia, Azienda USL Toscana Sudest, Grosseto. · U.O.C. Cardiologia Interventistica, Anthea Hospital, GVM Care & Research, Bari. · Dipartimento Cardiovascolare, Ospedale Cardarelli, Napoli. · Laboratorio di Emodinamica, U.O. Cardiologia, Ospedale G.B. Morgagni-L. Pierantoni, Forlì. · Dipartimento Cardiovascolare, Ospedali Riuniti, Università degli Studi, Trieste. · Cardiologia Interventistica, AOU Careggi, Firenze. · Dipartimento di Cardiologia, Ospedale degli Infermi, Rivoli (TO). · Cardiologia Interventistica, Ospedale S. Camillo-Forlanini, Roma. · Dipartimento Cardiovascolare, ASST Papa Giovanni XXIII, Bergamo. ·G Ital Cardiol (Rome) · Pubmed #27729667.

ABSTRACT: Drug-eluting stents (DES) are the current gold standard for percutaneous treatment of coronary artery disease. However, DES are associated with a non-negligible risk of long-term adverse events related to persistence of foreign material in the coronary artery wall. In addition, DES implantation causes permanent caging of the native vessel, thus impairing normal vasomotricity and the possibility of using non-invasive coronary imaging or preforming subsequent bypass surgery. On the contrary, coronary bioresorbable stents (BRS) may provide temporary mechanical support to coronary wall without compromising the subsequent recovery of normal vascular physiology, and have the potential to prevent late adverse events related to permanent elements. Several types of BRS have been introduced into clinical practice in Europe or are being tested. However, most of available clinical data relate to a single BRS, the Absorb bioresorbable Vascular Scaffold (Absorb BVS) (Abbott Vascular, Santa Clara, CA). Despite encouraging clinical results, no societal guidelines are available on the use of BRS in clinical practice.A panel of Italian expert cardiologists assembled under the auspices of the Italian Society of Interventional Cardiology (SICI-GISE) for comprehensive discussion and consensus development, with the aim to provide recommendations on the use of bioresorbable stents in terms of clinical indications, procedural aspects, post-percutaneous coronary angioplasty pharmacologic treatment and follow-up. Based on current evidence and BRS availability in Italian cath-labs, the panel decided unanimously to provide specific recommendations for the Absorb BVS device. These recommendations do not necessarily extend to other BRS, unless specified, although significant overlap may exist with Absorb BVS, particularly in terms of clinical rationale.

3 Guideline [SICI-GISE position paper on standards and guidelines for diagnostic and catheterization laboratories]. 2015

Piccaluga, Emanuela / Marchese, Alfredo / Varbella, Ferdinando / Sardella, Gennaro / Danzi, Gian Battista / Salvi, Alessandro / Cremonesi, Alberto / Merelli, Antonella / Ciarma, Lorenzo / Magro, Beatrice / Bedogni, Francesco / Anonymous8150844. ·Cardiologia 1-Emodinamica, A.O. Ospedale Niguarda Ca' Granda, Milano. · U.O. Cardiologia Interventistica, Anthea Hospital, GVM Care & Research, Bari. · Dipartimento di Cardiologia, Ospedale degli Infermi, Rivoli (TO). · Dipartimento di Scienze Cardiovascolari, Respiratorie, Nefrologiche, Anestesiologiche e Geriatriche, Sapienza Università di Roma, Roma. · U.O. Cardiologia, Ospedale Santa Corona, Pietra Ligure (SV). · Emodinamica Diagnostica e Interventistica, Azienda Ospedaliero-Universitaria "Ospedali Riuniti", Trieste. · Laboratorio di Cardio-Angiologia Diagnostica ed Interventistica, Maria Cecilia Hospital, GVM Care & Research, Cotignola (RA). · U.O. Cardiologia 2, Azienda Ospedaliero-Universitaria Pisana, Pisa. · U.O. Emodinamica, Policlinico S. Orsola-Malpighi, Bologna. · UOSD Diagnostica ed Interventistica Cardiovascolare Endoluminale, Ospedale Civile "S. Maria della Misericordia", ULSS 18, Rovigo. · Dipartimento di Cardiologia, IRCCS Policlinico San Donato, San Donato Milanese (MI). ·G Ital Cardiol (Rome) · Pubmed #26444219.

ABSTRACT: In the last few years, the activity of cath labs has undergone some notable changes, at present largely focusing on diagnosis and invasive therapy of a broad spectrum of cardiovascular diseases. Technological and pharmacological advances have allowed for procedures to be performed in patients who are increasingly complex, and cath labs have become the preferred venue for endovascular treatment of coronary artery disease, in particular acute coronary syndrome, as well as the treatment of structural heart disease and peripheral vascular disease. This position paper is an update of the 1996 and 2008 versions, given the present level of experience and the situation in Italy. It aims to provide the quality standards required to maintain adequate conditions of know-how and safety, as well as the structural and organizational requirements that are fundamental to obtain the best possible use of human and technological resources. Position papers should be a stimulus and guide for operators in the field as well as for those who govern health policies. This should allow for an improved and more rational allocation of cath labs in Italy, based on the real need for procedures and an optimal distribution and organization of the cardiovascular emergency networks while respecting the minimum standards of care.

4 Guideline [Position paper of the Italian Society of Invasive Cardiology (SICI-GISE) on indications for coronary angiography in patients with stable angina]. 2015

Marchese, Alfredo / Rossini, Roberta / Basile, Marco / Bedogni, Francesco / Danzi, Gian Battista / Musumeci, Giuseppe / Paradies, Valeria / Piccaluga, Emanuela / Sardella, Gennaro / Varbella, Ferdinando / Giordano, Arturo / Berti, Sergio / Anonymous8140844. ·U.O.C. Cardiologia Interventistica, Anthea Hospital, GVM Care & Research, Bari. · Dipartimento Cardiovascolare, A.O. Papa Giovanni XXIII, Bergamo. · Dipartimento di Cardiologia, IRCCS Policlinico San Donato, San Donato Milanese (MI). · U.O. Cardiologia, Ospedale Santa Corona, Pietra Ligure (SV). · Cardiologia 1-Emodinamica, A.O. Ospedale Niguarda Ca' Granda, Milano. · Dipartimento di Scienze Cardiovascolari, Respiratorie, Nefrologiche, Anestesiologiche e Geriatriche, Sapienza Università di Roma, Roma. · Dipartimento di Cardiologia, Ospedale degli Infermi, Rivoli (TO). · U.O.C. Cardiologia Interventistica, Clinica Pineta Grande, Castel Volturno (CE). · U.O. Cardiologia Diagnostica ed Interventistica, Fondazione Toscana "Gabriele Monasterio", Ospedale del Cuore, Massa. ·G Ital Cardiol (Rome) · Pubmed #26444218.

ABSTRACT: Available data suggest a steep increase in stable coronary artery disease with age. Its prevalence reaches a peak of almost 12-14% in men aged 65-84 years with an annual mortality ranging from 1.2% to 2.4%. The diagnosis of stable angina is primarily based on history and therefore relies on clinical judgment. In addition, its diagnosis can be extremely challenging because of the frequent transition from unstable to stable angina. Current European guidelines on the management of stable coronary artery disease give increased importance to the pre-test probability, which strongly affects the diagnostic algorithms. Imaging techniques play a greater role in the diagnosis of stable angina than in the past. Conversely, despite recent advances in technology and in the physiological assessment of coronary stenosis, an ever decreasing relevance is conferred to coronary angiography. Another difficult and controversial issue relates to the prognostic benefit of myocardial revascularization. The aim of this position paper is to review the most relevant clinical aspects of the European guidelines on the management of stable coronary artery disease.

5 Guideline Drug-coated balloon treatment of coronary artery disease: a position paper of the Italian Society of Interventional Cardiology. 2014

Cortese, Bernardo / Berti, Sergio / Biondi-Zoccai, Giuseppe / Colombo, Antonio / Limbruno, Ugo / Bedogni, Francesco / Cremonesi, Alberto / Silva, Pedro Leon / Sgueglia, Gregory A / Anonymous3690766. ·Interventional Cardiology, A.O. Fatebenefratelli Milano, Italy. ·Catheter Cardiovasc Interv · Pubmed #23934956.

ABSTRACT: Drug-coated balloons are a new tool for the treatment of patients with coronary artery disease. The main feature of this technology is a rapid and homogenous transfer of an antiproliferative drug (paclitaxel) to the vessel wall just at the time of balloon inflation, when neointimal proliferation, in response to angioplasty, is the highest. Moreover, drug-coated balloons share adjuntive advantages over stents: the absence of permanent scaffold and polymer, the respect of the original coronary anatomy, and limited inflammatory stimuli, thereby allowing for short-term dual antiplatelet therapy. To this day, a lot of devices are available in the market, with limited scientific data for the vast majority of them. Thus, the Italian scientific society of interventional cardiologists GISE decided to coordinate the efforts of a group of reknown experts on the field, in order to obtain a Position Paper on the correct use of drug-coated balloons in all the settings of coronary artery disease, giving a class of indication to each one, based on the clinical evidence. This Position Paper represents a quick reference for operators, investigators, and manufactures to promote the understanding and the correct use of the drug-coated balloon technology in everyday clinical practice.

6 Editorial Predictive value of C-reactive protein after drug-eluting stent implantation: an update view. 2018

Montone, Rocco A / Niccoli, Giampaolo. ·Department of Cardiovascular & Thoracic Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Università Cattolica del Sacro Cuore, Rome, Italy. ·Future Cardiol · Pubmed #30232900.

ABSTRACT: -- No abstract --

7 Editorial "Protected" PCI: time to act. 2018

Burzotta, Francesco / Crea, Filippo. ·Institute of Cardiology, Catholic University of the Sacred Heart, A. Gemelli University Hospital, Rome, Italy - francesco.burzotta@unicatt.it. · Institute of Cardiology, Catholic University of the Sacred Heart, A. Gemelli University Hospital, Rome, Italy. ·Minerva Cardioangiol · Pubmed #29687701.

ABSTRACT:

8 Editorial Cardiac hybrid imaging for the management of patients with known or suspected coronary artery disease. 2018

Andreini, Daniele / Conte, Edoardo / Mushtaq, Saima. ·Centro Cardiologico Monzino, IRCCS, Milan, Italy; Department of Clinical Sciences and Community Health, Cardiovascular Section, University of Milan, Milan, Italy. Electronic address: daniele.andreini@ccfm.it. · Centro Cardiologico Monzino, IRCCS, Milan, Italy. ·Int J Cardiol · Pubmed #29657048.

ABSTRACT: -- No abstract --

9 Editorial Bioresorbable Scaffolds: A Complex Journey to the "Promised Land". 2017

Colombo, Antonio / Azzalini, Lorenzo. ·Division of Interventional Cardiology, Cardio-Thoracic-Vascular Department, San Raffaele Scientific Institute, Milan, Italy. Electronic address: colombo.antonio@hsr.it. · Division of Interventional Cardiology, Cardio-Thoracic-Vascular Department, San Raffaele Scientific Institute, Milan, Italy. ·JACC Cardiovasc Interv · Pubmed #29216998.

ABSTRACT: -- No abstract --

10 Editorial Cardiac-CT in 2017: Over the coronary artery assessment. 2017

Andreini, Daniele / Conte, Edoardo / Mushtaq, Saima. ·Centro Cardiologico Monzino, IRCCS, Milan, Italy; Department of Clinical Sciences and Community Health, Cardiovascular Section, University of Milan, Milan, Italy. Electronic address: daniele.andreini@ccfm.it. · Centro Cardiologico Monzino, IRCCS, Milan, Italy. ·Int J Cardiol · Pubmed #28970038.

ABSTRACT: -- No abstract --

11 Editorial Percutaneous treatment of left main disease: Still learning about the optimal PCI strategy. 2016

Ancona, Marco / Chieffo, Alaide. ·Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy. · Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy. Electronic address: chieffo.alaide@hsr.it. ·Cardiovasc Revasc Med · Pubmed #27988083.

ABSTRACT: -- No abstract --

12 Editorial Is there any relationship between cardiopulmonary capacity and cardiovascular mechanics in coronary artery disease? 2016

Tadic, Marijana / Cuspidi, Cesare. ·University Clinical Hospital Centre "Dr. Dragisa Misovic - Dedinje", School of Medicine, University of Belgrade; Belgrade-Serbia. marijana_tadic@hotmail.com. · University of Milan-Bicocca and Instituto Auxologico Italiano, Clinical Research Unit; Meda-Italy. ·Anatol J Cardiol · Pubmed #27716726.

ABSTRACT: -- No abstract --

13 Editorial Screening CT Angiography in Asymptomatic Diabetes Mellitus? 2016

Andreini, Daniele. ·Centro Cardiologico Monzino, IRCCS, Milan, Italy; Department of Clinical Sciences and Community Health, Cardiovascular Section, University of Milan, Milan, Italy. Electronic address: daniele.andreini@ccfm.it. ·JACC Cardiovasc Imaging · Pubmed #27639766.

ABSTRACT: -- No abstract --

14 Editorial A coronary solution to manage a vascular peripheral obstruction post transcatheter aortic valve implantation. 2016

Yazdani, Kaveh O / Jabbour, Richard J / Mangieri, Antonio / Cacucci, Michele / Colombo, Antonio / Latib, Azeem. ·Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy. · Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy; Interventional Cardiology Unit, EMO-GVM Centro Cuore Columbus, Milan, Italy. · Cardiology Department, Ospedale Maggiore, Crema, Italy. · Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy; Interventional Cardiology Unit, EMO-GVM Centro Cuore Columbus, Milan, Italy. Electronic address: info@emocolumbus.it. ·Int J Cardiol · Pubmed #27522383.

ABSTRACT: -- No abstract --

15 Editorial The Clinical Significance and Management Implications of Chronic Total Occlusion Associated With Surgical Coronary Artery Revascularization. 2016

Azzalini, Lorenzo. ·San Raffaele Scientific Institute, Milan, Italy. Electronic address: azzalini.lorenzo@hsr.it. ·Can J Cardiol · Pubmed #27140947.

ABSTRACT: -- No abstract --

16 Editorial Continued vorapaxar versus withdrawed clopidogrel both on top of low dose aspirin in patients undergoing heart surgery: A call for randomized trial. 2016

Serebruany, Victor L / Kim, Moo Hyun / Golukhova, Elena / Pya, Yury / Bekbossynova, Makhabbat / Cattaneo, Marco / Marciniak, Thomas A. ·Johns Hopkins University, Baltimore, MD, USA. Electronic address: vserebr1@jhmi.edu. · Clinical Trials Unit, Dong-A University, Busan, South Korea. · Bakoulev Center for Cardiovascular Surgery, Moscow, Russia. · National Research Cardiac Surgery Center, Astana, Kazakhstan. · University of Milan, Milan, Italy. · FDA, Bethesda, MD, USA. ·Int J Cardiol · Pubmed #27128545.

ABSTRACT: Despite advanced techniques and improved clinical outcomes, the optimal antiplatelet strategy following coronary artery bypass grafting (CABG) is an unsolved mystery. Vorapaxar, a novel platelet thrombin receptor (PAR-1/4) blocker, is currently approved for post-myocardial infarction and peripheral artery disease indications on top of clopidogrel or/and aspirin. We here summarize the outcomes in patients after CABG for justification of a future vorapaxar trial. We comprehended the CABG outcomes after vorapaxar yielded from TRACER, TRA2P trials, and affiliated FDA reviews. The verified evidence suggests that composite of death, myocardial infarction and stroke occurred in 2.2% of vorapaxar vs. 8.1% placebo in TRA2P. These data were similar to the endpoint differences (5.9% after vorapaxar vs. 8.3% for placebo) in TRACER. The mortality reduction also consistently suggests vorapaxar advantage (1.7% vs. 2.5% in TRA2P, and 1.7% vs. 3.9% in TRACER). Notably, the post-CABG bleeding risks after vorapaxar were only slightly, but not significantly higher. Moreover, the bleeding disadvantage in the experimental arm was most likely related to overtreatment since majority of patients in both TRACER and TRA2P received triple antiplatelet therapy with aspirin, clopidogrel on top of vorapaxar. Overall, the FDA-confirmed evidence advocate for the future vorapaxar post-CABG outcome-driven trial. The head-to-head trial testing dual therapy with continued over CABG vorapaxar versus withdrawed clopidogrel, both on top of low dose aspirin is warranted. We conclude that the primary outcomes including mortality were consistently better for heart surgery patients after vorapaxar, while the excess of bleeding was mild. Continuing vorapaxar during CABG may be superior to currently recommended withdrawal antiplatelet strategies, and should be tested in an adequately powered randomized outcome-driven trial.

17 Editorial Anatomy and physiology in ischaemic heart disease: a second honeymoon? 2016

Pontone, Gianluca. ·Centro Cardiologico Monzino, IRCCS, Milan, Italy gianluca.pontone@ccfm.it. ·Eur Heart J · Pubmed #26787439.

ABSTRACT: -- No abstract --

18 Editorial CAD in TAVI patients: relevance of disease complexity. 2015

Stefanini, Giulio G / Panico, Cristina. ·Cardiovascular Department, Humanitas Research Hospital, Rozzano, Milan, Italy. ·EuroIntervention · Pubmed #26298413.

ABSTRACT: -- No abstract --

19 Editorial Structure and functioning of the Heart Team: primum non nocere. 2015

Stefanini, Giulio G / Kolh, Philippe. ·Cardiovascular Department, Humanitas Research Hospital, Rozzano, Milan, Italy. · Department of Cardiovascular Surgery, University Hospital (CHU, ULg) of Liège, Liège, Belgium philippe.kolh@chu.ulg.ac.be. ·Eur J Cardiothorac Surg · Pubmed #26242899.

ABSTRACT: -- No abstract --

20 Editorial Ezetimibe and Plaque Regression: Cholesterol Lowering or Pleiotropic Effects? 2015

Crea, Filippo / Niccoli, Giampaolo. ·Institute of Cardiology, Catholic University of the Sacred Heart, Rome, Italy. Electronic address: filippo.crea@rm.unicatt.it. · Institute of Cardiology, Catholic University of the Sacred Heart, Rome, Italy. ·J Am Coll Cardiol · Pubmed #26227187.

ABSTRACT: -- No abstract --

21 Editorial Experience and accuracy can result in parity of outcomes following one or two stents for left main stem bifurcation disease. 2015

Colombo, Antonio / Ruparelia, Neil. ·Department of Interventional Cardiology, San Raffaele Scientific Institute, Milan, Italy. · EMO-GVM, Centro Cuore Columbus, Milan, Italy. · Imperial College, London, United Kingdom. ·Catheter Cardiovasc Interv · Pubmed #25999274.

ABSTRACT: -- No abstract --

22 Editorial On diet, exercise … and arterial grafting. 2015

Gaudino, Mario. ·Department of Cardiothoracic Surgery, Weill Cornell Medical College, New York, USA; Department of Cardiovascular Sciences, Catholic University, Rome, Italy. Electronic address: mfg9004@med.cornell.edu. ·Int J Cardiol · Pubmed #25897914.

ABSTRACT: -- No abstract --

23 Editorial When you ask yourself the question "should I protect the side branch?": the answer is "yes". 2015

Colombo, Antonio / Ruparelia, Neil. ·San Raffaele Scientific Institute, Milan, Italy. Electronic address: info@emocolumbus.it. · San Raffaele Scientific Institute, Milan, Italy; Imperial College, London, United Kingdom. ·JACC Cardiovasc Interv · Pubmed #25616816.

ABSTRACT: -- No abstract --

24 Editorial Acute coronary syndromes without obstructive coronary atherosclerosis: the tiles of a complex puzzle. 2014

Lanza, Gaetano A / Crea, Filippo. ·From the Department of Cardiologic Sciences, Università Cattolica del Sacro Cuore, Rome, Italy. · From the Department of Cardiologic Sciences, Università Cattolica del Sacro Cuore, Rome, Italy. filippo.crea@rm.unicatt.it. ·Circ Cardiovasc Interv · Pubmed #24944301.

ABSTRACT: -- No abstract --

25 Editorial Decision making between percutaneous coronary intervention or bypass surgery in multi-vessel coronary disease. 2014

Buchanan, Gill Louise / Giustino, Gennaro / Chieffo, Alaide. ·Department of Cardiology, North Cumbria University Hospitals NHS Trust, Carlisle, United Kingdom. · Interventional Cardiology Unit, San Raffaele Scientific Hospital, Milan, Italy. · Interventional Cardiology Unit, San Raffaele Scientific Hospital, Milan, Italy. Electronic address: chieffo.alaide@hsr.it. ·Rev Esp Cardiol (Engl Ed) · Pubmed #24863589.

ABSTRACT: -- No abstract --

Next